Europe Does About-Face On Transgender Therapy For Children

The UK’s National Health Services restricted the use of puberty blockers to clinical trials

According to the Wall Street Journal, five countries – the U.K., Sweden, Finland, Norway, and France – are now cautioning doctors to exercise caution in their treatment of minors, citing a lack of evidence that the benefits of transgender therapy outweigh the risks.

Earlier this month, the UK’s National Health Services restricted the use of puberty blockers to clinical trials, effectively banning their use in children.

“These countries have done systematic reviews of evidence,” said transgender care researcher Leor Sapir at the right-leaning Manhattan Institute think tank. “They’ve found that the studies cited to support these medical interventions are too unreliable, and the risks are too serious.”

American politicians have taken notice

“It’s beneficial to see European countries coming to their senses,” said Rep. Dan Crenshaw (R-TX) in an interview, referring to the UK’s systematic evidentiary reviews of puberty blockers. According to the report, Republicans plan to make transgender-care issues part of their 2024 election platform.

“This is the issue of our time. This is a hill we’re gonna die on,” said Crenshaw.

source zerohedge.com